The Effect of Leucine on Carnitine Transport to Skeletal Muscle
NCT ID: NCT05009654
Last Updated: 2021-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
16 participants
INTERVENTIONAL
2016-10-01
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A secondary aim of this project is to investigate the effect of carnitine with leucine supplementation on muscle strength and body composition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Carnitine Supplementation and Resistance Training on Skeletal Muscle Function
NCT03907592
Carnitine Supplementation and Bone Mineral Density
NCT05120011
Leucine Supplementation Strategies to Enhance Muscle Anabolic Responses in Older Age
NCT06567665
The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients
NCT00643773
Study to Assess the Effect of Leucine Along With Resistance Exercise on Muscle Strength and Quality of Life in Elders
NCT00929929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
carnitine + leucine
1000 mg L-carnitine with 3000 mg L-leucine per day for 24 weeks
L-carnitine
L-leucine
leucine
4000 mg L-leucine per day for 24 weeks
L-leucine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-carnitine
L-leucine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* liver disease
* kidney disease
* neuromuscular disease
* gastrointestinal disorders (including stomach ulcers and erosions)
* diabetes
* other severe chronic diseases
18 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Gdansk
OTHER
Gdansk University of Physical Education and Sport
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Olek
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014/15/B/NZ7/00893
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
NCN_ROL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.